RBC to price trigger jump notes linked to SPDR S&P Biotech ETF

By Angela McDaniels

Tacoma, Wash., Nov. 13 – Royal Bank of Canada plans to price 0% trigger jump securities due Jan. 5, 2017 linked to the SPDR S&P Biotech exchange-traded fund, according to an FWP filing with the Securities and Exchange Commission.

If the final share price is greater than or equal to the initial share price, the payout at maturity will be par of $10 plus 25.75%. Investors will receive par if the ETF declines by 15% or less and will be exposed to losses from the initial share price if the ETF declines by more than 15%.

RBC Capital Markets LLC is the agent. Distribution is through Morgan Stanley Wealth Management.

The notes will price Nov. 30.

The Cusip number is 78013C229.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.